Literature DB >> 25216852

Oral health in oncology: impact of immunotherapy.

Leanne K Jackson1, Douglas B Johnson, Jeffrey A Sosman, Barbara A Murphy, Joel B Epstein.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25216852     DOI： 10.1007/s00520-014-2434-6

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  23 in total

1.  Evaluation of cytotoxic T-cell activation, chemokine receptors, and adhesion molecules in blood and serum in patients with oral lichen planus.

Authors:  Filiz Namdar Pekiner; Gulderen Y Demirel; Mehmet O Borahan; Semih Ozbayrak
Journal:  J Oral Pathol Med       Date:  2012-03-09       Impact factor: 4.253

Review 2.  Pathogenesis of oral lichen planus--a review.

Authors:  M R Roopashree; Rajesh V Gondhalekar; M C Shashikanth; Jiji George; S H Thippeswamy; Abhilasha Shukla
Journal:  J Oral Pathol Med       Date:  2010-10-04       Impact factor: 4.253

3.  Exercise therapy for trismus in head and neck cancer.

Authors:  P U Dijkstra; M W Sterken; R Pater; F K L Spijkervet; J L N Roodenburg
Journal:  Oral Oncol       Date:  2006-09-18       Impact factor: 5.337

Review 4.  Cytokine responses against periodontal infection: protective and destructive roles.

Authors:  Yen-Chun G Liu; Ulf H Lerner; Yen-Tung A Teng
Journal:  Periodontol 2000       Date:  2010-02       Impact factor: 7.589

5.  Improved survival with ipilimumab in patients with metastatic melanoma.

Authors:  F Stephen Hodi; Steven J O'Day; David F McDermott; Robert W Weber; Jeffrey A Sosman; John B Haanen; Rene Gonzalez; Caroline Robert; Dirk Schadendorf; Jessica C Hassel; Wallace Akerley; Alfons J M van den Eertwegh; Jose Lutzky; Paul Lorigan; Julia M Vaubel; Gerald P Linette; David Hogg; Christian H Ottensmeier; Celeste Lebbé; Christian Peschel; Ian Quirt; Joseph I Clark; Jedd D Wolchok; Jeffrey S Weber; Jason Tian; Michael J Yellin; Geoffrey M Nichol; Axel Hoos; Walter J Urba
Journal:  N Engl J Med       Date:  2010-06-05       Impact factor: 91.245

6.  Long-term oral effects in patients treated with radiochemotherapy for head and neck cancer.

Authors:  Aline Lima da Silva Deboni; Adelmo José Giordani; Nilza Nelly Fontana Lopes; Rodrigo Souza Dias; Roberto Araujo Segreto; Siri Beier Jensen; Helena Regina Comodo Segreto
Journal:  Support Care Cancer       Date:  2012-03-13       Impact factor: 3.603

7.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

Authors:  Suzanne L Topalian; F Stephen Hodi; Julie R Brahmer; Scott N Gettinger; David C Smith; David F McDermott; John D Powderly; Richard D Carvajal; Jeffrey A Sosman; Michael B Atkins; Philip D Leming; David R Spigel; Scott J Antonia; Leora Horn; Charles G Drake; Drew M Pardoll; Lieping Chen; William H Sharfman; Robert A Anders; Janis M Taube; Tracee L McMiller; Haiying Xu; Alan J Korman; Maria Jure-Kunkel; Shruti Agrawal; Daniel McDonald; Georgia D Kollia; Ashok Gupta; Jon M Wigginton; Mario Sznol
Journal:  N Engl J Med       Date:  2012-06-02       Impact factor: 91.245

Review 8.  Oral graft-versus-host disease.

Authors:  Mark M Schubert; Maria Elvira Pizzigatti Correa
Journal:  Dent Clin North Am       Date:  2008-01

Review 9.  Oral and dental management of the cancer patient: prevention and treatment of complications.

Authors:  M S Chambers; B B Toth; J W Martin; T J Fleming; J C Lemon
Journal:  Support Care Cancer       Date:  1995-05       Impact factor: 3.603

Review 10.  MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.

Authors:  Rajesh V Lalla; Joanne Bowen; Andrei Barasch; Linda Elting; Joel Epstein; Dorothy M Keefe; Deborah B McGuire; Cesar Migliorati; Ourania Nicolatou-Galitis; Douglas E Peterson; Judith E Raber-Durlacher; Stephen T Sonis; Sharon Elad
Journal:  Cancer       Date:  2014-02-25       Impact factor: 6.860
View more
  8 in total

1.  Oral mucositis-case series of a rare adverse effect associated with immunotherapy.

Authors:  Hardik Sheth; Ramya Pragya; Shama Kovale; Mandar Deshpande; Rajesh Mistry; Aditya Shreenivas; Sewanti Limaye
Journal:  Support Care Cancer       Date:  2021-01-29       Impact factor: 3.603

2.  Squamous cell carcinoma associated with chronic graft versus host disease-like/lichen planus-like lesion of the oral cavity in a patient managed for metastatic melanoma with a PD-1 inhibitor pembrolizumab.

Authors:  Adepitan A Owosho; Joseph Randazzo; Evan B Rosen; Cherry L Estilo; Joseph M Huryn; Ping Chi; SaeHee K Yom
Journal:  Oral Oncol       Date:  2016-10-13       Impact factor: 5.337

3.  Supportive care for patients undergoing immunotherapy.

Authors:  Bernardo Leon Rapoport; Ronwyn van Eeden; Vincent Sibaud; Joel B Epstein; Jean Klastersky; Matti Aapro; Devan Moodley
Journal:  Support Care Cancer       Date:  2017-07-13       Impact factor: 3.603

Review 4.  Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors.

Authors:  Emmanuelle Vigarios; Joel B Epstein; Vincent Sibaud
Journal:  Support Care Cancer       Date:  2017-02-22       Impact factor: 3.603

Review 5.  Immune checkpoint inhibitor-related dermatologic adverse events.

Authors:  Amaris N Geisler; Gregory S Phillips; Dulce M Barrios; Jennifer Wu; Donald Y M Leung; Andrea P Moy; Jeffrey A Kern; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2020-05-23       Impact factor: 11.527

Review 6.  An Overview of Clinical Oncology and Impact on Oral Health.

Authors:  Jack A Harris; Giulia Ottaviani; Nathaniel S Treister; Glenn J Hanna
Journal:  Front Oral Health       Date:  2022-04-25

7.  Immune Toxicity with Checkpoint Inhibition for Metastatic Melanoma: Case Series and Clinical Management.

Authors:  Anna J Lomax; Jennifer Lim; Robert Cheng; Arianne Sweeting; Patricia Lowe; Neil McGill; Nicholas Shackel; Elizabeth L Chua; Catriona McNeil
Journal:  J Skin Cancer       Date:  2018-01-21

Review 8.  Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis.

Authors:  Herve Y Sroussi; Joel B Epstein; Rene-Jean Bensadoun; Deborah P Saunders; Rajesh V Lalla; Cesar A Migliorati; Natalie Heaivilin; Zachary S Zumsteg
Journal:  Cancer Med       Date:  2017-10-25       Impact factor: 4.452
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.